Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Scotty Here for Reason!!!!

<< Previous

Bullboard Posts

Next >>

Comment by losingmyshirton Mar 16, 2021 8:26pm

164 Views

Post# 32813664

RE:RE:Scotty Here for Reason!!!!

Scotty wrote: This company is a scam. I was taken in, I wish to warn future investors of that fact. That's it.

Scotty,

No need to explain anything to the Pretentious Pumpers Maui and Dookie.
Depending on the day, they accuse people of being Bashers or Shorters?

Let them have their fun. Both believe (or do they) that Kaly is on the right track. That in itself shows how bright they actually are.

Enjoy the weekend

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?